Journal Article

Inhibition of IDO leads to IL-6-dependent systemic inflammation in mice when combined with photodynamic therapy

Boon, Louis, Stachura, Joanna, Golab Jakub, Tonecka Katarzyna, Fidyt Klaudyna, Wachowska Malgorzata, Braniewska Agata, Kotula Iwona, Rygiel, Tomasz Piotr, Sas Zuzanna, Muchowicz Angelika

2020

Overview

It was previously reported that the activation of antitumor immune response by photodynamic therapy (PDT) is crucial for its therapeutic outcome. Excessive PDT-mediated inflammation is accompanied by immunosuppressive mechanisms that protect tissues from destruction. Thus, the final effect of PDT strongly depends on the balance between the activation of an adoptive arm of immune response and a range of activated immunosuppressive mechanisms. Here, with flow cytometry and functional tests, we evaluate the immunosuppressive activity of tumor-associated myeloid cells after PDT. We investigate the antitumor potential of PDT combined with indoleamine 2,3-dioxygenase 1 (IDO) inhibitor in the murine 4T1 and E0771 orthotopic breast cancer models. We found that the expression of IDO, elevated after PDT, affects the polarization of T regulatory cells and influences the innate immune response. Our results indicate that, depending on a therapeutic scheme, overcoming IDO-induced immunosuppressive mechanisms after PDT can be beneficial or can lead to a systemic toxic reaction. The inhibition of IDO, shortly after PDT, activates IL-6-dependent toxic reactions that can be diminished by the use of anti-IL-6 antibodies. Our results emphasize that deeper investigation of the physiological role of IDO, an attractive target for immunotherapies of cancer, is of great importance.

• Publisher: Springer Nature B.V
• Subject: Antitumor activity / Breast cancer / Flow cytometry / Immune response / Immunoregulation / Immunosuppressive agents / Immunotherapy / Inflammation / Innate immunity / Interleukin 6 / Lymphocytes T / Myeloid cells / Photodynamic therapy / Tryptophan 2,3-dioxygenase